More From The Market Online
With osteo Phase 3 trial at 50% recruitment, Paradigm Bio inks partnership with University of London
Paradigm Biopharma (ASX:PAR) has this week hit two big items out the park: first of all, hitting 50% recruitment
- Jonathon Davidson
- 2 mins
- 02 April 2026 15:13 (AEST)
Emyira ramps up national growth strategy with NSW recruitment campaign
Emyira has initiated a significant growth program with a targeted clinical workforce recruitment campaign underway in…
- Colin Sandell-Hay
- 2 mins
- 02 April 2026 11:56 (AEST)
Introducing Prairie Lithium: Saskatchewan’s permitted lithium project ready to scale
We've spoken to Prairie Lithium founder Zach Maurer about the explorer's overall mission, right after Macquarie's…
- Isaac McIntyre
- 1 min
- 31 March 2026 16:17 (AEST)
